[PDF] Current approach to diagnosis and management of chronic
Research Progress in Chronic Lymphocytic Leukemia
(PDF) Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice
(PDF) Guidelines for diagnosis, indications for treatment, response
Cancer Treatment and Research 64
(PDF) European LeukemiaNet recommendations for the management of
VIDEO
Acute myeloid leukemia (AML) // by Dr Sohrab
Chronic myeloid leukemia (CML) // Dr Sohrab
Acute Myeloid Leukemia: Novel Targeted Therapies
Leukemia Research Foundation
Acute myeloid leukaemia and cytogenetic and molecular abnormalities
Amy Hair Shave
COMMENTS
Guide for authors
Introduction Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics ...
Guide to Authors
Article: An Article is a substantial, in-depth, novel research study of interest to the readership of the journal. The structure an Article should follow is detailed below. Specifications ...
Leukemia Research
1.1 CiteScore. Official journal of the Myelodysplastic Syndromes Foundation. Leukemia Research Reports (LRR), a companion title to Leukemia Research, is a peer-reviewed publication devoted to the rapid publication of short, high-quality papers related to a broad scope of therapeutic areas of hematology, including …. View full aims & scope.
For Authors & Referees
Guide to Authors All the key information you will require when preparing a manuscript for submission to Leukemia including article type specifications and formatting guidelines. Please read this ...
Leukemia ResearchReports: Guide for authors
Guide for authors. Leukemia Research Reports is an open access, international journal which delivers timely information online to all health care professionals involved in basic and/or applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. It does this by rapidly publishing a range of peer ...
Leukemia
Leukemia is one of the leading journals in hematology and oncology. It covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered ...
Advances in Leukemia Research
NCI-funded researchers are working to advance our understanding of how to treat leukemia. With progress in both targeted therapies and immunotherapies, leukemia treatment has the potential to become more effective and less toxic. This page highlights some of the latest research in leukemia, including clinical advances that may soon translate ...
Diagnosis and management of AML in adults: 2022 recommendations from an
Since the 2017 report from the European LeukemiaNet (ELN), 1 there has been substantial progress in our knowledge of acute myeloid leukemia (AML). Recent advances significantly influence clinical practice. These advances include insights into the clinical value of genomic abnormalities for diagnosis and prognosis, the clinical significance of inherited predisposition to AML, technological ...
Leukemia & Lymphoma
Leukemia & Lymphoma is an international peer reviewed journal that publishes research on all aspects of hematological malignancies. The journal aims to address the needs of physicians and scientists interested in clinical, translational, laboratory and basic science research, as well as clinical diagnosis and treatment of patients with malignant hematological disorders.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021
The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regarding factors with prognostic importance, and are intended to aid physicians with clinical decision-making. These NCCN Guidelines Insights focus on ...
Leukemia & Lymphoma: Vol 65, No 5 (Current issue)
Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Matthew M. Lei, Mark N. Sorial, Uvette Lou, Michelle Yu, Andrea Medrano, Josie Ford, Ronald A. Nemec, Jeremy S. Abramson & Jacob D. Soumerai. Pages: 653-659.
Annals of Leukemia Research
Author Guidelines. Authors are instructed to follow the guidelines before submission of manuscript to Annals of Leukemia Research. Peer Review : Annals of Leukemia Research follows double blinded peer review process where authors and reviewers donot know the identities of each other and kept confidential. Publication Ethics : Articles published under Annals of Leukemia Research follow COPE ...
American Society of Hematology 2020 guidelines for treating newly
Older adults with acute myeloid leukemia (AML) represent a vulnerable population in whom disease-based and clinical risk factors, pati ... American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults ... in palliative-care patients with cancer. 164 The authors described the outcomes for ...
Author Guidelines
Author Guidelines. For 'Defining the role of authors and contributors', ... Authors should also declare that any research involving people, medical records, ... 'Adapted from Berger et al. Leukemia 2003, 17, 1820-1826; with permission.' 12.1.6. Legend to figures.
American Journal of Leukemia Research
Author Guidelines Submission. ... Submission of a manuscript to the American Journal of Leukemia Research journal directly implies that all the authors have read and agreed to the journal's guidelines. The content present in the manuscript after publication will be freely available to all the potential readers over the Internet for ...
Editorial Process
The cost for open access publication in Leukemia for a full article is £3,060/ $4,480/ €3,580; for a letter to the editor the cost is £1,835/ $2,690/ €2,150 (VAT or local taxes will be added ...
Leukemia Research template
Leukemia Research. Approved by publishing and review experts on SciSpace, this template is built as per for Leukemia Research formatting guidelines as mentioned in Elsevier author instructions. The current version was created on and has been used by 134 authors to write and format their manuscripts to this journal. Hematology. Oncology.
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
Patients with newly diagnosed chronic myeloid leukemia (CML) need long-term therapy with high efficacy and safety. Asciminib, a BCR::ABL1 inhibitor specifically targeting the ABL myristoyl pocket, ...
Information for Authors: Clinical Lymphoma, Myeloma and Leukemia
Author Information. Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma &Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of ...
A Clinical Perspective on Plasma Cell Leukemia: A Single-Center Experience
Circulating plasma cells (CPCs) are detected in most multiple myeloma (MM) patients, both at diagnosis and on relapse. A small subset, plasma cell leukemia (PCL), represents a different biology and has a poor prognosis. In this retrospective analysis, we evaluated patients with primary (pPCL, n = 35) or secondary (sPCL, n = 49), with ≥5% CPCs and a smaller subset with lower CPCs of 1-4% (n ...
Dr. Stuart Winter publishes decades-long research in premier journal
Dr. Stuart Winter, chief research officer, is one of 52 authors on a paper that will soon be published in "Nature," the world's leading multidisciplinary science journal.The study is titled "The Genomic Basis of T-Lineage Acute Lymphoblastic Leukemia (T-ALL)." The study builds upon a concept that Dr. Winter and his colleagues first started in 2001: that the use of nelarabine, an ...
New role of tumor suppressor STAT3β discovered in leukemia
Sophie Edtmayer, Ph.D. student and first author of the study, says, "We were able to show by RNA sequencing analyses that the loss of STAT3β leads to an increase in interferon-dependent signals ...
A rare incidence of severe dermatological toxicities triggered by
All-trans retinoic acid (ATRA) is an indispensable part of the treatment of acute promyelocytic leukemia (APL). Although, mild cutaneous toxicities like mucocutaneous xerosis, rash, and pruritus are well reported, ATRA associated severe dermatological toxicities are extremely rare. ATRA is primary metabolized by cytochrome P450 (CYP450) enzyme system, and triazole antifungals are notorious for ...
Journal Information
Journal Information. Aims and Scope. Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of ...
"Rosetta Stone" of cell signaling could expedite precision cancer
The research was funded by the Charles and Marjorie Holloway Foundation, the MIT Center for Precision Cancer Medicine, the Koch Institute Frontier Research Program via L. Scott Ritterbush, the Leukemia and Lymphoma Society, the National Institutes of Health, Cancer Research UK, the Brain Tumour Charity, and the Koch Institute Support (core ...
Localized Merkel cell carcinoma treatment considerations: a response to
Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine tumour of the skin with poor prognosis and rising global incidence. A recently published article in BMC Cancer, titled "Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre" (Wang et al.), provides a contemporary analysis of locoregional disease outcomes in Australia which highlights the ...
Gender inclusivity of ophthalmology journal submission guidelines and
Although the ethical and scientific imperative of gender equity is widely recognized, few scholarly journals describe gender-inclusive research practices in their submission guidelines. 1,17 A recent cross-sectional analysis of 121 active obstetrics and gynecology journals found that only 33.9% provided explicit author instructions on gender ...
IMAGES
VIDEO
COMMENTS
Introduction Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics ...
Article: An Article is a substantial, in-depth, novel research study of interest to the readership of the journal. The structure an Article should follow is detailed below. Specifications ...
1.1 CiteScore. Official journal of the Myelodysplastic Syndromes Foundation. Leukemia Research Reports (LRR), a companion title to Leukemia Research, is a peer-reviewed publication devoted to the rapid publication of short, high-quality papers related to a broad scope of therapeutic areas of hematology, including …. View full aims & scope.
Guide to Authors All the key information you will require when preparing a manuscript for submission to Leukemia including article type specifications and formatting guidelines. Please read this ...
Guide for authors. Leukemia Research Reports is an open access, international journal which delivers timely information online to all health care professionals involved in basic and/or applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. It does this by rapidly publishing a range of peer ...
Leukemia is one of the leading journals in hematology and oncology. It covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered ...
NCI-funded researchers are working to advance our understanding of how to treat leukemia. With progress in both targeted therapies and immunotherapies, leukemia treatment has the potential to become more effective and less toxic. This page highlights some of the latest research in leukemia, including clinical advances that may soon translate ...
Since the 2017 report from the European LeukemiaNet (ELN), 1 there has been substantial progress in our knowledge of acute myeloid leukemia (AML). Recent advances significantly influence clinical practice. These advances include insights into the clinical value of genomic abnormalities for diagnosis and prognosis, the clinical significance of inherited predisposition to AML, technological ...
Leukemia & Lymphoma is an international peer reviewed journal that publishes research on all aspects of hematological malignancies. The journal aims to address the needs of physicians and scientists interested in clinical, translational, laboratory and basic science research, as well as clinical diagnosis and treatment of patients with malignant hematological disorders.
The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regarding factors with prognostic importance, and are intended to aid physicians with clinical decision-making. These NCCN Guidelines Insights focus on ...
Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Matthew M. Lei, Mark N. Sorial, Uvette Lou, Michelle Yu, Andrea Medrano, Josie Ford, Ronald A. Nemec, Jeremy S. Abramson & Jacob D. Soumerai. Pages: 653-659.
Author Guidelines. Authors are instructed to follow the guidelines before submission of manuscript to Annals of Leukemia Research. Peer Review : Annals of Leukemia Research follows double blinded peer review process where authors and reviewers donot know the identities of each other and kept confidential. Publication Ethics : Articles published under Annals of Leukemia Research follow COPE ...
Older adults with acute myeloid leukemia (AML) represent a vulnerable population in whom disease-based and clinical risk factors, pati ... American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults ... in palliative-care patients with cancer. 164 The authors described the outcomes for ...
Author Guidelines. For 'Defining the role of authors and contributors', ... Authors should also declare that any research involving people, medical records, ... 'Adapted from Berger et al. Leukemia 2003, 17, 1820-1826; with permission.' 12.1.6. Legend to figures.
Author Guidelines Submission. ... Submission of a manuscript to the American Journal of Leukemia Research journal directly implies that all the authors have read and agreed to the journal's guidelines. The content present in the manuscript after publication will be freely available to all the potential readers over the Internet for ...
The cost for open access publication in Leukemia for a full article is £3,060/ $4,480/ €3,580; for a letter to the editor the cost is £1,835/ $2,690/ €2,150 (VAT or local taxes will be added ...
Leukemia Research. Approved by publishing and review experts on SciSpace, this template is built as per for Leukemia Research formatting guidelines as mentioned in Elsevier author instructions. The current version was created on and has been used by 134 authors to write and format their manuscripts to this journal. Hematology. Oncology.
Patients with newly diagnosed chronic myeloid leukemia (CML) need long-term therapy with high efficacy and safety. Asciminib, a BCR::ABL1 inhibitor specifically targeting the ABL myristoyl pocket, ...
Author Information. Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma &Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of ...
Circulating plasma cells (CPCs) are detected in most multiple myeloma (MM) patients, both at diagnosis and on relapse. A small subset, plasma cell leukemia (PCL), represents a different biology and has a poor prognosis. In this retrospective analysis, we evaluated patients with primary (pPCL, n = 35) or secondary (sPCL, n = 49), with ≥5% CPCs and a smaller subset with lower CPCs of 1-4% (n ...
Dr. Stuart Winter, chief research officer, is one of 52 authors on a paper that will soon be published in "Nature," the world's leading multidisciplinary science journal.The study is titled "The Genomic Basis of T-Lineage Acute Lymphoblastic Leukemia (T-ALL)." The study builds upon a concept that Dr. Winter and his colleagues first started in 2001: that the use of nelarabine, an ...
Sophie Edtmayer, Ph.D. student and first author of the study, says, "We were able to show by RNA sequencing analyses that the loss of STAT3β leads to an increase in interferon-dependent signals ...
All-trans retinoic acid (ATRA) is an indispensable part of the treatment of acute promyelocytic leukemia (APL). Although, mild cutaneous toxicities like mucocutaneous xerosis, rash, and pruritus are well reported, ATRA associated severe dermatological toxicities are extremely rare. ATRA is primary metabolized by cytochrome P450 (CYP450) enzyme system, and triazole antifungals are notorious for ...
Journal Information. Aims and Scope. Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of ...
The research was funded by the Charles and Marjorie Holloway Foundation, the MIT Center for Precision Cancer Medicine, the Koch Institute Frontier Research Program via L. Scott Ritterbush, the Leukemia and Lymphoma Society, the National Institutes of Health, Cancer Research UK, the Brain Tumour Charity, and the Koch Institute Support (core ...
Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine tumour of the skin with poor prognosis and rising global incidence. A recently published article in BMC Cancer, titled "Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre" (Wang et al.), provides a contemporary analysis of locoregional disease outcomes in Australia which highlights the ...
Although the ethical and scientific imperative of gender equity is widely recognized, few scholarly journals describe gender-inclusive research practices in their submission guidelines. 1,17 A recent cross-sectional analysis of 121 active obstetrics and gynecology journals found that only 33.9% provided explicit author instructions on gender ...